SCHEMBL26833641

SCHEMBL26833641

c1ccc2cc(-c3ccc4c(ccc5cc(N(c6ccc(-c7cc8ccccc8c8ccncc78)cc6)c6ccc(-c7cc8ccccc8c8ccncc78)cc6)ccc54)c3)ccc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 2/20 0.47
CYP17A1 P05093 1/20 0.43
CYP19A1 P11511 1/20 0.43
CYP11B2 P19099 1/20 0.43
MAPK9 P45984 3/20 0.41
MAPK10 P53779 3/20 0.41
MAPK8 P45983 2/20 0.41
TDO2 P48775 2/20 0.38
HIPK2 Q9H2X6 3/20 0.36
CSNK1D P48730 1/20 0.36
MAPK11 Q15759 1/20 0.36
MAPK14 Q16539 1/20 0.36
CSNK2A1 P68400 1/20 0.36
TNF P01375 1/20 0.36
KDM4E B2RXH2 1/20 0.36
POLB P06746 1/20 0.36
HTT P42858 1/20 0.36
RAD52 P43351 1/20 0.36
CCNC P24863 4/20 0.36
CDK8 P49336 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26833640 0.96 CYP11B1 (0.45) CYP11B1CYP17A1CYP19A1CYP11B2MAPK9
SCHEMBL26833634 0.95 CYP11B1 (0.47) CYP11B1CYP17A1CYP19A1CYP11B2MAPK9
SCHEMBL26833632 0.95 CYP11B1 (0.47) CYP11B1CYP17A1CYP19A1CYP11B2MAPK9
SCHEMBL26834665 0.91 TNF (0.47) CYP11B1CYP17A1CYP19A1CYP11B2MAPK9
SCHEMBL26834663 0.91 CYP11B1 (0.43) CYP11B1CYP17A1CYP19A1CYP11B2MAPK9
SCHEMBL23448779 0.86 ESR1 (0.42) CYP11B1CYP17A1CYP19A1CYP11B2MAPK9
SCHEMBL26833466 0.86 CYP11B1 (0.43) CYP11B1CYP17A1CYP19A1CYP11B2MAPK9
SCHEMBL26833469 0.86 TNF (0.55) CYP11B1CYP17A1CYP19A1CYP11B2MAPK9
SCHEMBL26833548 0.86 CYP11B1 (0.43) CYP11B1CYP17A1CYP19A1CYP11B2MAPK9
SCHEMBL26833551 0.85 CYP11B1 (0.43) CYP11B1CYP17A1CYP19A1CYP11B2MAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-11-09 US disclosed
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-11-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF AHR, ORAI3, WNT3 CYP11B1 968/4885CYP17A1 560/4885CYP19A1 318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.